Literature DB >> 25695620

Human Umbilical Cord Mesenchymal Stem Cells Promote Breast Cancer Metastasis by Interleukin-8- and Interleukin-6-Dependent Induction of CD44(+)/CD24(-) Cells.

Fengxia Ma1, Dandan Chen, Fang Chen, Ying Chi, Zhibo Han, Xiaoming Feng, Xue Li, Zhongchao Han.   

Abstract

Although emerging evidence links mesenchymal stem cells (MSCs) with cancer metastasis, the underlying mechanisms are poorly understood. In the present study, we found that human umbilical cord-derived MSCs (UC-MSCs) promoted MCF-7 cell migration in vitro and metastasis in vivo. To explore the mechanisms, the characteristics of MCF-7 cells cocultured with UC-MSCs were assessed. The expression and secretion of interleukin-8 (IL-8) and IL-6 were induced in MCF-7 cells cocultured with UC-MSCs. However, neutralization of IL-8 or IL-6 secreted by UC-MSCs could attenuate the enhanced expression of IL-8 and IL-6 in MCF-7 cells cocultured with UC-MSCs, which subsequently alleviated the enhanced migration. Similar to UC-MSCs, exogenous human recombinant IL-8 or IL-6 also promoted IL-8 and IL-6 expression and MCF-7 cell migration. In addition to enhanced IL-8 and IL-6 expression, MCF-7 cells cocultured with UC-MSCs displayed enhanced mammosphere-forming ability and increased percentage of CD44(+)/CD24(-) cells. However, epithelial-to-mesenchymal transition (EMT) was not observed in MCF-7 cells cocultured with UC-MSCs. Taken together, these results suggested that IL-8 and IL-6 secreted by UC-MSCs activated the autocrine IL-8 and IL-6 signaling in MCF-7 cells and induced CD44(+)/CD24(-) cells, which subsequently promoted MCF-7 cell migration in vitro and metastasis in vivo.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25695620     DOI: 10.3727/096368915X687462

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  19 in total

Review 1.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

Review 2.  Breast cancer stem cell: the roles and therapeutic implications.

Authors:  Fang Yang; Jing Xu; Lin Tang; Xiaoxiang Guan
Journal:  Cell Mol Life Sci       Date:  2016-08-16       Impact factor: 9.261

Review 3.  Umbilical cord mesenchymal stem cells and breast cancer: a good therapeutic candidate or not? A minireview.

Authors:  Anahita Tavakoli; Mohammad Saeed Kahrizi; Kimia Safa; Reza ArefNezhad; Fatemeh Rezaei-Tazangi
Journal:  Mol Biol Rep       Date:  2022-08-08       Impact factor: 2.742

4.  The Antitumor Activity of hAMSCs Secretome in HT-29 Colon Cancer Cells Through Downregulation of EGFR/c-Src/IRTKS Expression and p38/ERK1/2 Phosphorylation.

Authors:  Shamin Ebadi Zavieh; Fatemeh Safari
Journal:  Cell Biochem Biophys       Date:  2022-02-12       Impact factor: 2.989

Review 5.  Human-derived normal mesenchymal stem/stromal cells in anticancer therapies.

Authors:  Cheng Zhang; Shi-Jie Yang; Qin Wen; Jiang F Zhong; Xue-Lian Chen; Andres Stucky; Michael F Press; Xi Zhang
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

6.  Effects of mesenchymal stem cells on solid tumor metastasis in experimental cancer models: a systematic review and meta-analysis.

Authors:  Jing-Huan Li; Wen-Shuai Fan; Mi-Mi Wang; Yan-Hong Wang; Zheng-Gang Ren
Journal:  J Transl Med       Date:  2018-04-27       Impact factor: 5.531

7.  Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.

Authors:  Andrew Sulaiman; Ze-Min Yao; Li-Sheng Wang
Journal:  J Biomed Res       Date:  2018-03-26

Review 8.  [Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for anti-tumor therapy].

Authors:  Ai Li; Tianyuan Zhang; Jianqing Gao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

Review 9.  Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.

Authors:  Daria S Chulpanova; Kristina V Kitaeva; Leysan G Tazetdinova; Victoria James; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

Review 10.  Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.

Authors:  Tareq Saleh; Liliya Tyutynuk-Massey; Emmanuel K Cudjoe; Michael O Idowu; Joseph W Landry; David A Gewirtz
Journal:  Front Oncol       Date:  2018-05-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.